Neurotrope, Inc. — Form D
Neurotrope, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2016-12-01. The offering totals $24.5M, of which $24.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-12-01
- Form: D
- Accession: 0001513856-16-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $24.5M
- Amount sold: $24.5M
- Investors: 221
- Date of first sale: 2016-11-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-275463
Issuer
- Name: Neurotrope, Inc.
- CIK: 0001513856
- Entity type: Corporation
- Jurisdiction: NEVADA
- Incorporated: 2013
- Address: 205 EAST 42ND STREET,, NEW YORK, NY, 10017
- Phone: (973) 242-0005
Officers, directors & promoters (23)
| Name | Role | Location |
|---|
| BRUCE BERNSTEIN | Director | Miami, FL |
| Kenneth Gorelick | Director | New York, NY |
| James Gottlieb | Director | New York, NY |
| Shana Phares | Director | New York, NY |
| Joshua Silverman | Director | NEW YORK, NY |
| WILLIAM SINGER | Director | NEW YORK, NY |
| Susanne Wilke | Director | New York, NY |
| Dan Alkon | Executive Officer | New York, NY |
| ROBERT WEINSTEIN | Executive Officer | NEW YORK, NY |
| Susanne Wilke | Executive Officer | New York, NY |
| WILLIAM SINGER | Executive Officer | NEW YORK, NY |
| PAUL E FREIMAN | Director | EMERYVILLE, CA |
| John Abeles | Director | Manassas, VA |
| Jay M Haft | Director | Salisbury, CT |
| Robert S Weinstein | Executive Officer | Newark, NJ |
| Larry D Altstiel, MD | Director | Newark, NJ |
| William E Singer | Director | Newark, NJ |
| Charles S Ramat | Director | Newark, NJ |
| Charles S Ramat | Executive Officer | Newark, NJ |
| James E Gottlieb | Director | Newark, NJ |
| James New | Director | Plantation, FL |
| James New | Executive Officer | Plantation, FL |
| Ralph Bean | Director | Bridgeport, WV |
Other filings by this issuer (2)
More